http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20170006938-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aea5ddac9cae108a5f80101c3f50a351
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 2015-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4eb103446e8d33e26d622274f1fd328a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fed4153943ef4639f5fd96d4c479feb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20c5f6e63e25ebb3d4aebe7c1f79e287
publicationDate 2017-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20170006938-A
titleOfInvention Pharmaceutical composition for preventing or treating chronic kidney disease
abstract The present invention relates to a pharmaceutical composition which halts the progression of chronic renal failure and effectively improves symptoms of chronic renal failure, thereby preventing or treating chronic renal failure effectively. To this end, the pharmaceutical composition includes fimasartan and a pharmaceutically acceptable salt thereof or a hydrate or a solvate thereof.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2646467-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022255760-A1
priorityDate 2015-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100354654-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419657112
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24445
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535245
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5707
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4275592
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11582
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588607
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518757
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22227373
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18591
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137319715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426025815
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450694124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448549201
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451822344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID157883379
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559508
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53471180

Total number of triples: 44.